Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation [0.03%]
心脏再同步治疗的探索性成本效益分析：系统设备优化与标准(非系统)优化的多国经济评估
Kurt Banz,Peter Paul Delnoy,Jean Renaud Billuart
Kurt Banz
Background: Recent studies provide evidence of improved clinical benefits associated with cardiac resynchronization therapy (CRT) optimization. Our analysis explores the cost-effectiveness of systematically optimized (SO,...
Aurélie Colas,Karine Danno,Cynthia Tabar et al.
Aurélie Colas et al.
Health authorities are constantly searching for new ways to stabilise health expenditures. To explore this issue, we compared the costs generated by different types of medical practice in French general medicine: i.e. conventional (CM-GP), ...
Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina [0.03%]
阿哌沙班相对于维生素K拮抗剂在阿根廷房颤管理中成本效益分析的估计
Mariano Anibal Giorgi,Christian Caroli,Norberto Damian Giglio et al.
Mariano Anibal Giorgi et al.
Apixaban, a novel oral anticoagulant which has been approved for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation, reduces both ischemic and haemorrhagic stroke and produces fewer bleedings than vitamin K a...
The Ebola contagion and forecasting virus: evidence from four African countries [0.03%]
非洲四国埃博拉疫情及病毒预测模型的实证研究
Selmi Nadhem,Hachicha D Nejib
Selmi Nadhem
This paper is focused on examining the number of deaths' increases participation in the propagating the Ebola virus during the period ranging from March to October 2014. An application of the MGARCH-DCC model regressions on four countries h...
Paying for the quantity and quality of hospital care: the foundations and evolution of payment policy in England [0.03%]
医院服务质量与数量的支付问题：英格兰支付政策的基础和演变
Katja Grašič,Anne R Mason,Andrew Street
Katja Grašič
Prospective payment arrangements are now the main form of hospital funding in most developed countries. An essential component of such arrangements is the classification system used to differentiate patients according to their expected reso...
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis [0.03%]
西班牙慢性肾病患者在透析前后使用镧碳酸盐的成本效果分析
Blanca Gros,Antonio Galán,Emilio González-Parra et al.
Blanca Gros et al.
Aims: In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calcium-based phosphate binders (CB). However, their use is associated with vascular calcification and an increased...
The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia [0.03%]
与非甾体抗炎药联合质子泵抑制剂相比 Celecoxib 治疗沙特关节炎的成本效益分析
Sherif A Nasef,A Aziz Shaaban,Joaquin Mould-Quevedo et al.
Sherif A Nasef et al.
Background: Cyclooxygenase (COX)-2 inhibitors including celecoxib are as effective as non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs) in the treatment of osteoarthritis (OA) and have less gastrointestinal ...
Cost-utility analysis of case management for frail older people: effects of a randomised controlled trial [0.03%]
针对体弱老年人的个案管理的成本效益分析：随机对照试验的影响
Magnus Sandberg,Ulf Jakobsson,Patrik Midlöv et al.
Magnus Sandberg et al.
Background: To evaluate the effects of a case management intervention for frail older people (aged 65+ years) by cost and utility. Materials and methods: ...
Lee R Mobley,Tzy-Mey Kuo,Jeffrey Traczynski et al.
Lee R Mobley et al.
Objectives: Examine how differences in state regulatory environments predict geographic disparities in the utilization of cancer screening. Data sources/s...
Requirements for benefit assessment in Germany and England - overview and comparison [0.03%]
德国和英国获益评估的要求-概述与比较
Victor Ivandic
Victor Ivandic
Background: This study compared the methodological requirements for early health technology appraisal (HTA) by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care (G-BA/IQWiG; Germany) and the ...